Reaffirmed annual double digit % profit growth over the medium term.
Commenting on CSL’s outlook, Dr. McKenzie said “The fundamentals of CSL's underlying business unitsare robust and we are in a strong position to deliver annualised double-digit earnings growth over themedium term.“For FY25, revenue growth is anticipated to be approximately 5-7% over FY24 at constant currency3. CSL’sNPATA1,2 for FY25 is anticipated to be in the range of approximately $3.2 billion to $3.3 billion at constantcurrency, representing growth over FY24 of approximately 10-13%.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$239.10 |
Change
0.240(0.10%) |
Mkt cap ! $115.7B | |||
| Open | High | Low | Value | Volume |
| $238.23 | $241.14 | $238.23 | $90.14M | 376.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 554 | $238.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $239.10 | 1999 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| CSL (ASX) Chart |